Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

GHRP-6 (Growth Hormone Releasing Peptide-6)vsCJC-1295 with DAC

A synthetic hexapeptide that signals your pituitary to release growth hormone through a unique pathway, with emerging evidence of heart-protective benefits.

Long-acting growth hormone releaser that works around the clock to boost your body's natural GH production with just one or two injections per week.

Growth HormoneGrowth Hormone

At a Glance

Quick
comparison

Dose Range

GHRP-6 (Growth Hormone Releasing Peptide-6)

100–300 mcg

CJC-1295 with DAC

1000–2000 mcg

Frequency

GHRP-6 (Growth Hormone Releasing Peptide-6)

Multiple times daily

CJC-1295 with DAC

Twice weekly

Administration

GHRP-6 (Growth Hormone Releasing Peptide-6)

Subcutaneous injection

CJC-1295 with DAC

Subcutaneous injection

Cycle Length

GHRP-6 (Growth Hormone Releasing Peptide-6)

8-12 weeks

CJC-1295 with DAC

8-12 weeks

Onset Speed

GHRP-6 (Growth Hormone Releasing Peptide-6)

Moderate (1-2 weeks)

CJC-1295 with DAC

Moderate (1-2 weeks)

Evidence Level

GHRP-6 (Growth Hormone Releasing Peptide-6)

Limited human trials

CJC-1295 with DAC

Moderate human trials (Phase 1-2)

Efficacy

Benefit
ratings

GHRP-6 (Growth Hormone Releasing Peptide-6)
CJC-1295 with DAC

Muscle Recovery and Growth

GHRP-6 (Growth Hormone Releasing Peptide-6)85%
CJC-1295 with DAC0%

Cellular Health and Protection

GHRP-6 (Growth Hormone Releasing Peptide-6)72%
CJC-1295 with DAC0%

Appetite and Nutrient Intake

GHRP-6 (Growth Hormone Releasing Peptide-6)88%
CJC-1295 with DAC0%

GH Elevation

GHRP-6 (Growth Hormone Releasing Peptide-6)0%
CJC-1295 with DAC92%

Convenience

GHRP-6 (Growth Hormone Releasing Peptide-6)0%
CJC-1295 with DAC95%

Recovery Support

GHRP-6 (Growth Hormone Releasing Peptide-6)0%
CJC-1295 with DAC88%

Technical Data

Compound
specifications

GHRP-6 (Growth Hormone Releasing Peptide-6)

Molecular Formula

C46H56N12O6

Molecular Weight

873.0 g/mol

Half-Life

~2.5 hours

Bioavailability

<1% oral, high subcutaneous

CAS Number

87616-84-0

CJC-1295 with DAC

Molecular Formula

C165H269N47O46

Molecular Weight

3647.28 g/mol

Half-Life

6-8 days

Bioavailability

~100% (subcutaneous)

CAS Number

863288-34-0

Protocols

Dosing
tiers

GHRP-6 (Growth Hormone Releasing Peptide-6)

starting

100 mcg per injection

1-2 times daily (morning and/or evening)

2-4 weeks

Begin with once-daily dosing to assess tolerance and individual response. Many users start with an evening injection to take advantage of natural nighttime GH pulses.

standard

150-200 mcg per injection

2-3 times daily (morning, afternoon, evening)

6-8 weeks

Most users find this range effective for sustained GH stimulation. Timing around workouts can maximize the anabolic response. Some space injections 4-6 hours apart.

advanced

250-300 mcg per injection

3+ times daily

8-12 weeks

Only for experienced users with good tolerance established. Higher frequency can lead to receptor desensitization, so cycling (e.g., 5 days on, 2 days off) may preserve effectiveness. Requires careful monitoring.

CJC-1295 with DAC

starting

1000 mcg (1 mg)

Once weekly

2-4 weeks

Start with once weekly dosing to assess tolerance and gauge your individual response to the peptide before increasing.

standard

1000-2000 mcg (1-2 mg)

Twice weekly

8-12 weeks

The most common protocol used in research and practice. Provides sustained GH elevation throughout the week with the long half-life.

advanced

2000 mcg (2 mg)

Twice weekly

12+ weeks

Higher dosing for maximum GH stimulation. Monitor for side effects like water retention and adjust as needed. Extended cycles require periodic breaks.

Applications

Best
suited for

GHRP-6 (Growth Hormone Releasing Peptide-6)

Athletes and Serious Trainers

If you're hitting the gym hard and want better recovery and muscle growth, GHRP-6 amplifies your body's natural GH response. This is particularly valuable during intense training phases when you want to maximize adaptation and minimize soreness. The appetite stimulation also helps you consume the calories you need to grow.

Those Exploring Novel Peptide Protocols

GHRP-6 offers a unique mechanism through the ghrelin receptor, making it valuable for users who want to explore diverse GH-stimulation pathways. It works distinctly from GHRH-based approaches and pairs well with other GH secretagogues for synergistic effects.

Longevity and Metabolic Health Enthusiasts

Growth hormone plays roles in metabolic health, body composition, and potentially aging markers. GHRP-6's emerging research on cellular protection and antioxidant activation makes it interesting for those interested in broader health optimization beyond just muscle growth.

CJC-1295 with DAC

Growth Hormone Optimization

CJC-1295 with DAC excels at providing a sustained, steady elevation of growth hormone levels. Unlike shorter-acting peptides that create brief spikes, the DAC modification keeps GH elevated for days, mimicking a more youthful hormone profile.

Muscle Building and Recovery

By increasing both GH and IGF-1 levels, this peptide supports protein synthesis and muscle repair. Users often notice improved recovery between workouts and better ability to build and maintain lean muscle mass.

Anti-Aging and Longevity

Growth hormone naturally declines with age, contributing to many signs of aging. CJC-1295 with DAC helps restore more youthful GH levels, potentially supporting better skin quality, energy levels, and overall vitality.

Body Composition Improvement

The combination of increased GH and IGF-1 promotes fat metabolism while preserving muscle tissue. Many users experience gradual fat loss, particularly in stubborn areas, while maintaining or building lean mass.

Convenient Weekly Dosing

Unlike peptides requiring daily or twice-daily injections, the extended half-life of CJC-1295 with DAC means just one or two injections per week provide continuous benefits. Ideal for those who want results without daily protocols.

Safety Profile

Side
effects

GHRP-6 (Growth Hormone Releasing Peptide-6)

Common

  • Increased Appetite
  • Mild Joint or Muscle Discomfort
  • Water Retention or Mild Swelling

Uncommon

  • Sleep Disturbances
  • Mild Dizziness or Lightheadedness

Serious

  • Allergic Reaction

CJC-1295 with DAC

Common

  • Injection site reactions
  • Water retention
  • Flushing
  • Tingling sensation

Uncommon

  • Headaches
  • Fatigue or lethargy
  • Joint discomfort

Serious

  • Carpal tunnel symptoms
  • Blood glucose elevation

Research Status

Safety
& evidence

GHRP-6 (Growth Hormone Releasing Peptide-6)

Evidence Level

Limited human trials

FDA Status

Research compound

Safety Overview

GHRP-6 has a relatively long research history dating back to 1981, with human studies demonstrating its ability to stimulate GH release. The good news is that animal safety studies show excellent tolerability at high doses, and the side effects reported are generally mild and reversible. However, it's not FDA-approved, so use is based on research evidence rather than pharmaceutical oversight. Always purchase from reputable sources and consider medical consultation, especially if you have existing health conditions.

Contraindications

  • xKnown allergy or sensitivity to any component of the peptide
  • xActive cancer or history of cancer without medical clearance
  • xSevere cardiovascular disease or uncontrolled hypertension
  • xAcute critical illness or sepsis

CJC-1295 with DAC

Evidence Level

Moderate human trials (Phase 1-2)

FDA Status

Research compound

Safety Overview

CJC-1295 with DAC was evaluated in Phase 1-2 human clinical trials where it demonstrated a generally favorable safety profile. The most common adverse events were mild injection site reactions including temporary pain, swelling, and redness. No serious adverse events were reported in the published clinical studies. The compound was being developed for HIV-associated lipodystrophy before the program was discontinued.

Contraindications

  • xActive cancer or history of malignancy
  • xPregnancy or breastfeeding
  • xPituitary tumors or disorders
  • xDiabetic retinopathy
  • xUncontrolled diabetes

Decision Guide

Which is
right for you?

Choose GHRP-6 (Growth Hormone Releasing Peptide-6) if...

  • Building lean muscle mass and improving body composition
  • Recovery from intense training programs and athletic performance
  • Supporting overall metabolic health and longevity markers
  • Exploring novel GH-stimulation pathways for those who respond well to peptide protocols

Choose CJC-1295 with DAC if...

  • Boosting natural growth hormone production
  • Building lean muscle mass
  • Improving body composition
  • Anti-aging and longevity